WebPraise for Jonas. Barry Greene taking over. Jonas will remain as chief innovation officer at Sage. Jonas spoke at length and said 155 words. (exechange) — Cambridge, … WebJeff joined SAGE as CEO in 2013 and has more than 20 years of experience on both the scientific and business sides of the pharmaceutical and healthcare industries, particularly in the CNS field. Before joining the SAGE team, Jeff served as President of the Regenerative Medicine Division of Shire plc and previously as Senior Vice President of Research and …

Jeff Jonas leaves Sage Therapeutics to launch biotech incubator

Web21 nov 2024 · CNBC's Meg Tirrell sits down with Sage CEO Jeff Jonas to talk about the biotechnology landscape and the company's work in depression drug trials. Web12 lug 2024 · SAGE +0.32 (+0.74%) Share Mad Money with Jim Cramer Depression should be treated like a broken leg or a seizure, says CEO of development-stage biotech Sage Therapeutics Jim Cramer sits down... lakelovers the low house

Sage

Web19 mar 2024 · Sage Therapeutics (NASDAQ: ... change in the way postpartum depression is thought about and treated moving forward,” said Jeff Jonas, M.D., chief executive officer of Sage. “We are ... Web31 mar 2024 · I’m proud of the way our employees, partners, and the community have responded in this unprecedented time,” said Jeff Jonas, M.D., chief executive officer at Sage Therapeutics. “The teams at Sage are handling virtual work well, and progress across our pipeline remains strong. WebOn this week’s Tech Nation, it’s about developing medicines which enable the body to heal itself. First up, treating depression in a whole new way … and rapidly. Dr. Jeff Jonas, the Chief Innovation Officer and Director of Sage Therapeutics, talks about their drug Zuranolone, nearing the end of its drug approval journey. hellboy collection